Probiotics for caries prevention: A narrative review
Source abstract
Abstract
Dental caries, a widespread global health problem, results from oral microbiome dysbiosis dominated by acidogenic pathogens like Streptococcus mutans . Conventional preventive methods, such as fluoride and antimicrobial rinses, often lack specificity and can disrupt beneficial microbes. Probiotics are live, health-promoting bacteria or yeasts commonly found in foods such as yogurt or in dietary supplements. They help restore microbial balance and have emerged as a promising strategy for caries management. This review explores the mechanisms, efficacy, and clinical applications of probiotics in caries prevention. Specific strains such as Lactobacillus reuteri , Lactobacillus rhamnosus , and Streptococcus salivarius inhibit cariogenic bacteria through competitive exclusion, acidity modulation via arginine metabolism, and production of antimicrobial compounds like reuterin and bacteriocins. Clinical trials show that probiotic lozenges, gums, and dairy products reduce Streptococcus mutans counts and caries incidence in both children and adults. Challenges remain in optimizing strain selection, delivery methods, and ensuring long-term efficacy. Innovations include engineered probiotics with enhanced antimicrobial activity and synbiotics that combine probiotics with prebiotic fibers to improve colonization. While probiotics provide a safe, non-invasive adjunct to traditional approaches, further large-scale, well-designed longitudinal studies are essential to standardize protocols and understand their ecological effects on the oral microbiome. In summary, integrating probiotics into personalized oral care has the potential to revolutionize caries prevention by addressing microbial dysbiosis directly, shifting the focus from pathogen elimination to promoting a balanced microbiome. This highlights the significance of probiotics in supporting oral and dental health and potentially reducing the prevalence of caries worldwide.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Oral microbiology and periodontitis research · Dental Health and Care Utilization · Probiotics and Fermented Foods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
ADA Forsyth Institute, Somerville, MA, USA
Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China
UCLA School of Dentistry, University of California, LA, USA
Funding
General Research Fund
References (100+)
Show source-provided references
1. World Health Organization. Global oral health status report: towards universal health coverage for oral health by 2030. World Health Organization, 2022.
2. 10.1177/002203451769356610.1177/0022034517693566 ↗
3. 10.3390/microorganisms1201012110.3390/microorganisms12010121 ↗
4. Marsh PD, Takahashi N, Nyvad B. Biofilms in caries development. Dent Caries Dis Clin Manage 2015: 107–131.
5. Marsh PD. Dental biofilms in health and disease. In: Pitts N (ed.) Understanding dental caries: from pathogenesis to prevention and therapy. Springer, 2016, pp.41–52.
6. 10.3389/fmedt.2021.76917210.3389/fmedt.2021.769172 ↗
7. Global oral health burden amounts to $442 billion. Brit Dent J 2015; 219: 311.
8. 10.1002/j.0022-0337.2005.69.5.tb03941.x10.1002/j.0022-0337.2005.69.5.tb03941.x ↗
9. 10.1007/s00784-012-0916-910.1007/s00784-012-0916-9 ↗
10. Sajjan P, Laxminarayan N, Kar PP, et al. Chlorhexidine as an antimicrobial agent in dentistry—a review. Oral Health Dent Manage 2016; 15: 93–100.
11. 10.1080/0001635031000779810.1080/00016350310007798 ↗
12. 10.3390/biomedicines1008180310.3390/biomedicines10081803 ↗
13. 10.1038/sj.bdj.2016.86510.1038/sj.bdj.2016.865 ↗
14. 10.1016/j.tifs.2019.07.04410.1016/j.tifs.2019.07.044 ↗
15. 10.1186/s12903-024-03893-810.1186/s12903-024-03893-8 ↗
16. 10.1186/s12903-024-04703-x10.1186/s12903-024-04703-x ↗
17. 10.1016/j.afres.2022.10018510.1016/j.afres.2022.100185 ↗
18. 10.1038/s41522-024-00488-710.1038/s41522-024-00488-7 ↗
19. 10.1021/acs.chemrev.2c0043110.1021/acs.chemrev.2c00431 ↗
20. 10.1038/s41392-024-01946-610.1038/s41392-024-01946-6 ↗
21. 10.1128/MMBR.00076-1510.1128/MMBR.00076-15 ↗
22. 10.1038/nrmicro225910.1038/nrmicro2259 ↗
23. 10.3389/fmicb.2020.0077410.3389/fmicb.2020.00774 ↗
24. James S, Tagg J. The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci. N Zeal Dent J 1991; 87: 80–83.
25. 10.2217/fmb.12.11310.2217/fmb.12.113 ↗
26. 10.2147/CCIDE.S9306610.2147/CCIDE.S93066 ↗
27. 10.1159/00035052410.1159/000350524 ↗
28. 10.1111/lam.1243410.1111/lam.12434 ↗
29. 10.1159/00023558110.1159/000235581 ↗
30. 10.1128/aem.02436-2110.1128/aem.02436-21 ↗
31. 10.1186/s12903-024-04659-y10.1186/s12903-024-04659-y ↗
32. 10.1186/s13213-024-01790-710.1186/s13213-024-01790-7 ↗
33. 10.1128/JB.02517-1410.1128/JB.02517-14 ↗
34. 10.1007/s00253-016-7531-710.1007/s00253-016-7531-7 ↗
35. 10.3389/fmicb.2017.0048610.3389/fmicb.2017.00486 ↗
36. 10.1099/jmm.0.056663-010.1099/jmm.0.056663-0 ↗
37. 10.1007/s40496-013-0007-210.1007/s40496-013-0007-2 ↗
38. 10.1128/IAI.68.5.2621-2629.200010.1128/IAI.68.5.2621-2629.2000 ↗
39. 10.1007/s12602-019-9521-410.1007/s12602-019-9521-4 ↗
40. 10.1007/s10266-019-00458-y10.1007/s10266-019-00458-y ↗
41. 10.3390/biom1405060510.3390/biom14050605 ↗
42. 10.1016/j.bioflm.2023.10013610.1016/j.bioflm.2023.100136 ↗
43. 10.1177/002203451037960210.1177/0022034510379602 ↗
44. 10.1007/s12602-014-9178-y10.1007/s12602-014-9178-y ↗
45. 10.1128/aem.02192-2410.1128/aem.02192-24 ↗
46. 10.3390/antibiotics1007079310.3390/antibiotics10070793 ↗
47. 10.1007/s12602-020-09712-010.1007/s12602-020-09712-0 ↗
48. 10.1111/j.1600-0722.1978.tb00623.x10.1111/j.1600-0722.1978.tb00623.x ↗
49. 10.7717/peerj.1016510.7717/peerj.10165 ↗
50. 10.1038/s41598-023-31474-210.1038/s41598-023-31474-2 ↗
51. 10.3390/nu1405112410.3390/nu14051124 ↗
52. 10.1016/j.jds.2019.01.00810.1016/j.jds.2019.01.008 ↗
53. 10.1007/s00784-020-03606-910.1007/s00784-020-03606-9 ↗
54. 10.1016/j.identj.2025.02.01810.1016/j.identj.2025.02.018 ↗
55. 10.1128/AEM.02702-1610.1128/AEM.02702-16 ↗
56. 10.1159/00035441210.1159/000354412 ↗
57. 10.5005/jp-journals-10005-252710.5005/jp-journals-10005-2527 ↗
58. 10.1080/0001635051002007010.1080/00016350510020070 ↗
59. 10.5005/jp-journals-10015-180010.5005/jp-journals-10015-1800 ↗
60. Guli M, Winarsih S, Barlianto W, et al. Mechanism of Lactobacillus reuteri probiotic in increasing intestinal mucosal immune system. Macedon J Med Sci 2021; 9: 784–793.
61. 10.1128/AEM.02116-1510.1128/AEM.02116-15 ↗
62. 10.1016/j.micpath.2020.10427910.1016/j.micpath.2020.104279 ↗
63. 10.1177/002203451770751210.1177/0022034517707512 ↗
64. 10.1111/omi.1204410.1111/omi.12044 ↗
65. 10.1099/mic.0.00023710.1099/mic.0.000237 ↗
66. 10.1186/s12903-021-01606-z10.1186/s12903-021-01606-z ↗
67. 10.1016/j.isci.2024.11157910.1016/j.isci.2024.111579 ↗
68. 10.1016/j.archoralbio.2016.07.00510.1016/j.archoralbio.2016.07.005 ↗
69. 10.17796/jcpd.38.4.p60831235325668410.17796/jcpd.38.4.p608312353256684 ↗
70. 10.1111/j.1600-051X.2010.01665.x10.1111/j.1600-051X.2010.01665.x ↗
71. 10.1155/2018/806364710.1155/2018/8063647 ↗
72. 10.3389/fimmu.2021.57838610.3389/fimmu.2021.578386 ↗
73. 10.4103/jisppd.jisppd_519_2010.4103/jisppd.jisppd_519_20 ↗
74. 10.1007/s13197-020-04857-w10.1007/s13197-020-04857-w ↗
75. Almabadi E, El Ashiry E, Alamoudi N, et al. Evaluation of Lactobacillus reuteri probiotic Lozenge intake on salivary cariogenic bacterial counts in preschool children: a randomized clinical trial. Med Sci 2020; 24: 259–269.
76. 10.17796/1053-4628-41.4.25710.17796/1053-4628-41.4.257 ↗
77. 10.1016/j.ifset.2013.04.00910.1016/j.ifset.2013.04.009 ↗
78. 10.1111/odi.1385410.1111/odi.13854 ↗
79. 10.3389/fmicb.2023.127626810.3389/fmicb.2023.1276268 ↗
80. 10.1016/j.identj.2024.06.01310.1016/j.identj.2024.06.013 ↗
81. 10.1159/00004748410.1159/000047484 ↗
82. Baxi S, Bhatia V, Tripathi AA, et al. Comparative evaluation of three probiotics for Streptococcus mutans prevention in plaque around orthodontic braces. Cureus 2023; 15: e37923.
83. 10.4103/JCD.JCD_467_2010.4103/JCD.JCD_467_20 ↗
84. 10.1016/j.job.2015.08.00410.1016/j.job.2015.08.004 ↗
85. 10.2478/jhsm-2024-000210.2478/jhsm-2024-0002 ↗
86. 10.1186/s12903-023-03756-810.1186/s12903-023-03756-8 ↗
87. 10.1093/cid/civ08510.1093/cid/civ085 ↗
88. 10.1016/j.aller.2020.04.00510.1016/j.aller.2020.04.005 ↗
89. 10.52547/fsct.17.104.6510.52547/fsct.17.104.65 ↗
90. 10.9734/EJNFS/2019/4563610.9734/EJNFS/2019/45636 ↗
91. 10.3389/fimmu.2022.84024510.3389/fimmu.2022.840245 ↗
92. 10.1016/j.jdent.2016.03.00210.1016/j.jdent.2016.03.002 ↗
93. 10.4103/JISPPD.JISPPD_323_1610.4103/JISPPD.JISPPD_323_16 ↗
94. Cohen PA. Probiotic safety—no guarantees. J Am Med Assoc Int Med 2018; 178: 1577–1578.
95. 10.1001/jama.2019.2226810.1001/jama.2019.22268 ↗
96. 10.1007/s10266-023-00804-110.1007/s10266-023-00804-1 ↗
97. 10.1186/1472-6831-12-4410.1186/1472-6831-12-44 ↗
98. 10.1007/s12602-018-9403-110.1007/s12602-018-9403-1 ↗
99. 10.1038/s41575-019-0173-310.1038/s41575-019-0173-3 ↗
100. 10.1080/20002297.2020.180930210.1080/20002297.2020.1809302 ↗